Correlation Between 180 Life and Navidea Biopharmaceutica
Can any of the company-specific risk be diversified away by investing in both 180 Life and Navidea Biopharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 180 Life and Navidea Biopharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 180 Life Sciences and Navidea Biopharmaceuticals, you can compare the effects of market volatilities on 180 Life and Navidea Biopharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 180 Life with a short position of Navidea Biopharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of 180 Life and Navidea Biopharmaceutica.
Diversification Opportunities for 180 Life and Navidea Biopharmaceutica
-0.38 | Correlation Coefficient |
Very good diversification
The 3 months correlation between 180 and Navidea is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding 180 Life Sciences and Navidea Biopharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Navidea Biopharmaceutica and 180 Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 180 Life Sciences are associated (or correlated) with Navidea Biopharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Navidea Biopharmaceutica has no effect on the direction of 180 Life i.e., 180 Life and Navidea Biopharmaceutica go up and down completely randomly.
Pair Corralation between 180 Life and Navidea Biopharmaceutica
If you would invest 374.00 in 180 Life Sciences on September 4, 2024 and sell it today you would lose (144.00) from holding 180 Life Sciences or give up 38.5% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 0.4% |
Values | Daily Returns |
180 Life Sciences vs. Navidea Biopharmaceuticals
Performance |
Timeline |
180 Life Sciences |
Navidea Biopharmaceutica |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
180 Life and Navidea Biopharmaceutica Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with 180 Life and Navidea Biopharmaceutica
The main advantage of trading using opposite 180 Life and Navidea Biopharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 180 Life position performs unexpectedly, Navidea Biopharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Navidea Biopharmaceutica will offset losses from the drop in Navidea Biopharmaceutica's long position.180 Life vs. Candel Therapeutics | 180 Life vs. Cingulate Warrants | 180 Life vs. Unicycive Therapeutics | 180 Life vs. Cardio Diagnostics Holdings |
Navidea Biopharmaceutica vs. NovaBay Pharmaceuticals | Navidea Biopharmaceutica vs. Cyclacel Pharmaceuticals | Navidea Biopharmaceutica vs. Tenax Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |